Sign inGet started

Ventures West 8 Limited Partnership

Insider CIK 1599970 · AQXP 10% owner · ALDR 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ALDR ALDER BIOPHARMACEUTICALS I C Conversion deriv2014-05-132014-05-15496,964— $00SEC↗
ALDR ALDER BIOPHARMACEUTICALS I C Conversion deriv2014-05-132014-05-15853,146— $00SEC↗
ALDR ALDER BIOPHARMACEUTICALS I C Conversion deriv2014-05-132014-05-15841,750— $00SEC↗
ALDR ALDER BIOPHARMACEUTICALS I C Conversion deriv2014-05-132014-05-151,027,668— $00SEC↗
ALDR ALDER BIOPHARMACEUTICALS I P Buy2014-05-132014-05-15250,000$10.00 $2.50M3,469,528SEC↗
ALDR ALDER BIOPHARMACEUTICALS I C Conversion2014-05-132014-05-153,219,528— $03,219,528SEC↗
AQXP AQUINOX PHARMACEUTICALS, I C Conversion deriv2014-03-122014-03-1440,147— $00SEC↗
AQXP AQUINOX PHARMACEUTICALS, I A Award deriv2014-03-122014-03-1436,502$11.00 $401.5K40,147SEC↗
AQXP AQUINOX PHARMACEUTICALS, I C Conversion deriv2014-03-122014-03-14378,786— $00SEC↗
AQXP AQUINOX PHARMACEUTICALS, I C Conversion deriv2014-03-122014-03-14378,786— $00SEC↗
AQXP AQUINOX PHARMACEUTICALS, I C Conversion deriv2014-03-122014-03-14378,786— $00SEC↗
AQXP AQUINOX PHARMACEUTICALS, I C Conversion deriv2014-03-122014-03-14325,035— $00SEC↗
AQXP AQUINOX PHARMACEUTICALS, I C Conversion deriv2014-03-122014-03-14325,035— $00SEC↗
AQXP AQUINOX PHARMACEUTICALS, I C Conversion deriv2014-03-122014-03-14325,035— $00SEC↗
AQXP AQUINOX PHARMACEUTICALS, I C Conversion deriv2014-03-122014-03-14326,538— $00SEC↗
AQXP AQUINOX PHARMACEUTICALS, I C Conversion deriv2014-03-122014-03-14326,538— $00SEC↗
AQXP AQUINOX PHARMACEUTICALS, I C Conversion deriv2014-03-122014-03-14326,538— $00SEC↗
AQXP AQUINOX PHARMACEUTICALS, I C Conversion deriv2014-03-122014-03-14189,393— $00SEC↗
AQXP AQUINOX PHARMACEUTICALS, I C Conversion deriv2014-03-122014-03-14189,393— $00SEC↗
AQXP AQUINOX PHARMACEUTICALS, I C Conversion deriv2014-03-122014-03-14189,393— $00SEC↗
AQXP AQUINOX PHARMACEUTICALS, I C Conversion deriv2014-03-122014-03-14284,090— $00SEC↗
AQXP AQUINOX PHARMACEUTICALS, I C Conversion deriv2014-03-122014-03-14284,090— $00SEC↗
AQXP AQUINOX PHARMACEUTICALS, I C Conversion deriv2014-03-122014-03-14284,090— $00SEC↗
AQXP AQUINOX PHARMACEUTICALS, I D To issuer2014-03-122014-03-14189,393— $00SEC↗
AQXP AQUINOX PHARMACEUTICALS, I D To issuer2014-03-122014-03-14378,786— $00SEC↗
AQXP AQUINOX PHARMACEUTICALS, I D To issuer2014-03-122014-03-14325,035— $00SEC↗
AQXP AQUINOX PHARMACEUTICALS, I D To issuer2014-03-122014-03-14326,538— $00SEC↗
AQXP AQUINOX PHARMACEUTICALS, I C Conversion2014-03-122014-03-141,543,989— $01,543,989SEC↗
AQXP AQUINOX PHARMACEUTICALS, I D To issuer2014-03-122014-03-14284,090— $00SEC↗
AQXP AQUINOX PHARMACEUTICALS, I D To issuer2014-03-122014-03-1440,147— $00SEC↗
AQXP AQUINOX PHARMACEUTICALS, I A Award2014-03-122014-03-1436,502— $040,147SEC↗